- Report
- October 2025
- 140 Pages
Global
From €2475EUR$2,800USD£2,145GBP
- Report
- December 2025
- 432 Pages
Global
From €4375EUR$4,950USD£3,791GBP
- Report
- April 2026
- 100 Pages
Global
From €2917EUR$3,300USD£2,527GBP
- Report
- March 2026
- 410 Pages
Global
From €2917EUR$3,300USD£2,527GBP
- Report
- February 2026
- 210 Pages
Global
From €2652EUR$3,000USD£2,298GBP
- Report
- January 2026
- 270 Pages
Global
From €2475EUR$2,800USD£2,145GBP
- Report
- January 2026
- 240 Pages
Global
From €2210EUR$2,500USD£1,915GBP
- Report
- January 2026
- 120 Pages
Global
From €2210EUR$2,500USD£1,915GBP
- Report
- November 2025
- 120 Pages
Global
From €2917EUR$3,300USD£2,527GBP
- Report
- October 2025
- 100 Pages
Global
From €2652EUR$3,000USD£2,298GBP
- Report
- June 2025
- 210 Pages
Global
From €2652EUR$3,000USD£2,298GBP
- Report
- December 2025
- 166 Pages
Global
From €4110EUR$4,650USD£3,561GBP
- Report
- November 2025
- 139 Pages
Global
From €4110EUR$4,650USD£3,561GBP
- Report
- February 2026
- 150 Pages
Global
From €5259EUR$5,950USD£4,557GBP
- Report
- May 2025
- 200 Pages
Global
From €2201EUR$2,490USD£1,907GBP
- Report
- January 2026
- 199 Pages
Global
From €3134EUR$3,545USD£2,715GBP
€3482EUR$3,939USD£3,017GBP
- Report
- January 2026
- 181 Pages
Global
From €3134EUR$3,545USD£2,715GBP
€3482EUR$3,939USD£3,017GBP
- Report
- January 2026
- 183 Pages
Global
From €3134EUR$3,545USD£2,715GBP
€3482EUR$3,939USD£3,017GBP
- Report
- January 2026
- 187 Pages
Global
From €3134EUR$3,545USD£2,715GBP
€3482EUR$3,939USD£3,017GBP
- Report
- January 2026
- 195 Pages
Global
From €3134EUR$3,545USD£2,715GBP
€3482EUR$3,939USD£3,017GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more